Searched for
PHARMA IMPORT TARIFFS
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...- India, Uzbekistan aim to double bilateral trade in 3 yearsIndia and Uzbekistan are set to significantly boost bilateral trade, aiming to double it within three years. Discussions at the recent Inte...
- 'Fastest we've ever put a trade deal into force': British High Commissioner to India Lindy Cameron hails India-UK trade dealThe India-UK Comprehensive Economic and Trade Agreement (CETA) will take effect on July 15, 2026, marking the fastest trade deal implementa...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- 30 Nifty stocks wipe out Rs 22.64 lakh crore investor wealth in 2026 so far; HDFC Bank, TCS lead routThirty Nifty 50 stocks have wiped out Rs 22.64 lakh crore in investor wealth this year. HDFC Bank and TCS led the decline, losing Rs 3.55 l...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Nifty to trade in 28,000–30,000 range in FY27 led by earnings: Smallcase managersSmallcase managers remain optimistic on India’s equity markets despite the Nifty declining over 9% this year, projecting the benchmark inde...
- Market will be volatile, look for an alternative solution: 5 large-caps from different sectors with upside potential of up to 30%A fall in crude oil prices can trigger a relief rally, which in fact it did in early trade on Thursday. But there is another reality as wel...
- Smallcaps rally! IIFL Finance, Hindustan Copper, Meesho, other stocks jump up to 7%Smallcap stocks, including IIFL Finance, Meesho, and GRSE, surged up to 7% on Wednesday, outperforming benchmark indices. This rally occurr...
- Secular, cyclical or war-dependent: A ratio to tell you what kind of growth you are buying. 6 stocks with upside potential of up to 29%Some valuation ratios are used because they are easy. The PE ratio is one of them. It is simple, familiar, and convenient. Not only for the...
- Additional US tariffs on Indian goods since April 2025: Here’s the full timelineThe United States imposed a series of tariffs on Indian goods starting April 2025. These duties varied, with some being reciprocal and othe...
- Pharma exports surpass $31 billion in FY26 despite global headwindsIndian pharmaceutical exports reached over $31 billion in FY26. March saw a significant 23% drop, primarily due to a slowdown in the United...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%We are living in times when the morning may see conciliatory exchanges between the US and Iran, leading to a cooling in crude oil prices. B...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- India–New Zealand sign 'once-in-a-generation' FTAIndia and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...
- Trump pushes pharma tariffs, but exemptions limit impactThe United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...
- Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...
- Trump’s 100% tariff spares Indian generics, but risks remain for pharma sectorUS President Donald Trump announced 100% tariffs on patented and branded drug imports. Indian generic drug makers face no immediate disrupt...
- Big US pharma stocks rise as Street reacts to Trump's tariff on drugsPresident Trump announced new 100 percent import taxes on branded pharmaceuticals. These tariffs begin October 1. Companies building US man...
Load More
